发明授权
- 专利标题： Uses of substantially pure interleukin-9 receptor
- 专利标题（中）： 使用实质性白细胞介素-9受体
-
申请号： US832192申请日： 1992-02-06
-
公开(公告)号： US5180678A公开(公告)日： 1993-01-19
- 发明人: Catherine Druez , Pierre Coulie , Catherine Uyttenhove , Jacques Van Snick
- 申请人： Catherine Druez , Pierre Coulie , Catherine Uyttenhove , Jacques Van Snick
- 专利权人： Ludwig Institute for Cancer Research
- 当前专利权人： Ludwig Institute for Cancer Research
- 主分类号： C07K14/705
- IPC分类号： C07K14/705 ; A61K38/00 ; C07K1/00 ; C07K14/00 ; C07K14/715 ; C12P21/00 ; G01N33/53
摘要：
The invention relates to substantially pure interleukin 9 receptor molecules and the use thereof. The uses include use as an interleukin-9 inhibitor, as a diagnostic agent for determining interleukin-9, and as a screening agent for pharmaceuticals. The interleukin-9 receptor is characterized as a glycoprotein of about 64 kilodaltons which, upon digestion with N-glycosidase F, yields a peptide of about 54 kilodaltons.
公开/授权文献
- US4681583A System for dispersing drug in biological environment 公开/授权日：1987-07-21
信息查询
